Filing Details
- Accession Number:
- 0001127430-15-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-13 16:08:20
- Reporting Period:
- 2015-05-12
- Filing Date:
- 2015-05-13
- Accepted Time:
- 2015-05-13 16:08:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1608778 | Mark Quigley | 10 Finderne Avenue Bridgewater NJ 08807 | Vice President, Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-12 | 12,656 | $15.61 | 12,656 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-12 | 12,656 | $22.07 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-05-12 | 6,094 | $15.61 | 6,094 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-12 | 6,094 | $22.07 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-12 | 12,656 | $0.00 | 12,656 | $15.61 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-12 | 6,094 | $0.00 | 6,094 | $15.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,344 | 2023-09-30 | No | 4 | M | Direct | |
| 31,250 | 2023-09-30 | No | 4 | M | Direct |
Footnotes
- Stock options granted under the Company's 2013 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant.
Billionaire Hedge Funds
